WallStreetZenWallStreetZen

NASDAQ: VRAX
Virax Biolabs Group Ltd Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Virax Biolabs Group earnings were -$6.6M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest VRAX earnings report on Sep 30, 2024 announced Q3 2024 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2024 ending Mar 31, 2024, VRAX reported annual earnings of -$6.7M, with 23.4% growth.

VRAX earnings history

Current Revenue
$84.9k
Current Earnings
-$6.6M
Current Profit Margin
-7,753.2%

VRAX Return on Equity

Current Company
-87.9%
Current Industry
19.9%
Current Market
35%
VRAX's Return on Equity (-87.9%)... subscribe to Premium to read more.
High Return on Equity Performance

VRAX undefined

Current Company
-79.9%
Current Industry
1.3%
VRAX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when VRAX announces earnings.

VRAX undefined

Current Company
-76.29%
Current Industry
14.3%
VRAX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

VRAX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
VRAX-$6.43M-$6.58MN/A-$2.61
SONN-$9.19M-$9.43MN/A-$10.19
OGEN-$10.54M-$10.57MN/A-$1.60
KTTA-$13.26M-$13.90MN/A-$12.69
MBIO-$14.92M-$15.75MN/A-$38.57
View Top Biotech Stocks

Virax Biolabs Group Earnings Reports & History FAQ

What were Virax Biolabs Group's earnings last quarter?

Virax Biolabs Group (NASDAQ: VRAX) reported Q3 2024 earnings per share (EPS) of N/A, up N/A year over year. Total VRAX earnings for the quarter were N/A. In the same quarter last year, Virax Biolabs Group's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Virax Biolabs Group stock.

Is Virax Biolabs Group profitable or losing money?

As of the last Virax Biolabs Group earnings report, Virax Biolabs Group is currently losing money. Virax Biolabs Group's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$6.58 million, a 4.96% decrease year over year.

What was VRAX's earnings growth in the past year?

As of Virax Biolabs Group's earnings date in Q2 2025, Virax Biolabs Group's earnings has grown year over year. VRAX earnings in the past year totalled -$6.58 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.